Brokerages Set M.D.C. Holdings, Inc. (NYSE:MDC) PT at $52.13

M.D.C. Holdings, Inc. (NYSE:MDC) has been assigned an average recommendation of “Reduce” from the five research firms that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating and four have assigned a hold rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $52.13.

A number of analysts have recently commented on MDC shares. Evercore ISI downgraded M.D.C. from an “outperform” rating to an “in-line” rating and upped their target price for the stock from $57.00 to $63.00 in a research note on Wednesday, January 31st. Raymond James restated a “market perform” rating on shares of M.D.C. in a research report on Wednesday, February 7th. Finally, StockNews.com started coverage on M.D.C. in a report on Sunday. They issued a “hold” rating on the stock.

M.D.C. Stock Performance

Shares of M.D.C. stock opened at $62.98 on Friday. The company has a 50 day moving average price of $62.86 and a 200 day moving average price of $55.87. The firm has a market capitalization of $4.73 billion, a P/E ratio of 11.93 and a beta of 1.54. M.D.C. has a 52 week low of $36.47 and a 52 week high of $63.00. The company has a quick ratio of 3.92, a current ratio of 9.76 and a debt-to-equity ratio of 0.50.

Insider Buying and Selling at M.D.C.

In other M.D.C. news, Director David E. Blackford sold 6,200 shares of M.D.C. stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $62.69, for a total value of $388,678.00. Following the transaction, the director now directly owns 13,534 shares in the company, valued at approximately $848,446.46. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 23.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On M.D.C.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Oppenheimer & Co. Inc. lifted its position in shares of M.D.C. by 0.6% in the fourth quarter. Oppenheimer & Co. Inc. now owns 34,954 shares of the construction company’s stock valued at $1,931,000 after acquiring an additional 198 shares in the last quarter. SummerHaven Investment Management LLC grew its position in M.D.C. by 1.4% during the fourth quarter. SummerHaven Investment Management LLC now owns 15,308 shares of the construction company’s stock valued at $846,000 after acquiring an additional 205 shares during the period. Arden Trust Co increased its position in M.D.C. by 5.3% during the 1st quarter. Arden Trust Co now owns 4,570 shares of the construction company’s stock worth $288,000 after purchasing an additional 232 shares in the last quarter. Nilsine Partners LLC raised its stake in shares of M.D.C. by 6.9% in the 4th quarter. Nilsine Partners LLC now owns 5,353 shares of the construction company’s stock valued at $296,000 after acquiring an additional 344 shares during the period. Finally, Quadrant Capital Group LLC lifted its stake in shares of M.D.C. by 23.2% during the fourth quarter. Quadrant Capital Group LLC now owns 1,965 shares of the construction company’s stock worth $109,000 after purchasing an additional 370 shares in the last quarter. 88.08% of the stock is owned by institutional investors and hedge funds.

M.D.C. Company Profile

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.